Clinical trial Recruiting at 1 site Observational Ages 18 and up

PEA and Scutellaria combined with exercise for chemotherapy-related nerve pain

Official title: Use of PEA and Scutellaria in Synergy With Therapeutic Exercise in Chemotherapy-induced Peripheral Neuropathy (CIPN): a Clinical Trial

Run by University of Palermo · NCT07352514 · Data updated 2026-11-12

This trial will see if taking PEA and Scutellaria together with therapeutic exercise helps adults who have nerve pain after chemotherapy.

More Neuropathic Pain trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Palermo
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Palermo, Italia)
StatusRecruiting
StartedMarch 15, 2025
Main results expectedFebruary 20, 2026
Study endsApril 2026
Registry record updatedJanuary 20, 2026
Trial IDNCT07352514 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 and older who developed neuropathic pain (NRS ≥ 5) after chemotherapy within the prior six months and who can follow the EXCAP exercise program may be eligible.

Probably not a fit

People with diabetic neuropathy, severe liver impairment, hypersensitivity to PEA, or severe disabilities preventing exercise are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective observational cohort in which adults with chemotherapy-induced peripheral neuropathy will be enrolled and followed while receiving post-market nutraceuticals and supervised exercise. Participants will be grouped to compare those receiving PEA plus Scutellaria with standardized therapeutic exercise against other treatment approaches. Outcomes will include patient-reported neuropathic pain severity and measures of nerve health over the follow-up period. The study uses a standardized exercise protocol (EXCAP) and requires a minimum opioid washout to limit confounding from opioid pain control.

Why it matters

Potential benefit: If successful, the combined nutraceutical and exercise approach could reduce neuropathic pain and improve nerve function and quality of life for people with CIPN.

How similar studies have gone: Smaller studies and case reports have suggested PEA can help neuropathic pain, but combining PEA and Scutellaria with structured exercise is relatively novel and not well established in randomized trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adults aged 18 years and older.
* Patients who have undergone chemotherapy treatment within the previous 6 months.
* Patients treated with PEA, Scutellaria, and standardized therapeutic exercise according to the EXCAP protocol from April 2025 to September 2025.
* Patients with a washout period from opioid-based analgesic therapy of at least 10 days or who are not receiving opioid-based analgesic therapy.
* Patients presenting with neuropathic pain (NRS ≥ 5).
* Patients able to provide written informed consent.

Exclusion Criteria:

* Patients younger than 18 years.
* Patients with hypersensitivity to PEA or any of the excipients listed in the Summary of Product Characteristics (SPC).
* Patients with diabetic pathology.
* Patients with severe hepatic impairment.
* Patients with severe disabilities that compromise the execution of therapeutic exercise.

Where it's running

  • A.O.U.P. P. Giaccone, Palermo, Italia 90127
    Palermo, Italia, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.